The Use of a Novel Heart Failure Agent in the Treatment of Pregnancy-Associated Cardiomyopathy

Table 1

Vital signs and medication regimen in the postpartum period.

Postpartum	SBP	DBP	HR	Medications
0 months	94	65	102	Carvedilol 6.25 mg BID, hydralazine 75-125-75 mg, isosorbide dinitrate 20 mg TID
1 month	95	65	94	Carvedilol 3.125 mg BID, enalapril 2.5 mg BID
2 months	100	70	109	Carvedilol 3.125 mg BID, enalapril 5 mg BID
3 months	96	72	103	Carvedilol 3.125 mg BID, enalapril 5 mg BID
4 months	92	65	90	Carvedilol 6.25 mg BID, Entresto 49-51 mg BID
5 months	90	60	77	Carvedilol 6.25 mg BID, Entresto 97-103 mg BID, bromocriptine 1.25 mg
6 months	94	61	77	Carvedilol 9.375 mg BID, Entresto 97-103 mg BID, bromocriptine 1.25 mg, eplerenone 25 mg
9 months	98	67	65	Carvedilol 9.375 mg BID, Entresto 97-103 mg BID, bromocriptine 1.25 mg, eplerenone 25 mg
12 months	112	77	81	Carvedilol 12.5 mg BID, Entresto 97-103 mg BID, bromocriptine 1.25 mg, eplerenone 25 mg
15 months	102	69	70	Carvedilol 12.5 mg BID, Entresto 97-103 mg BID, bromocriptine 1.25 mg, eplerenone 25 mg